ViiV Healthcare

ViiV Healthcare is a pharmaceutical company specializing in the development of therapies for HIV infection that was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company. In 2012 Shionogi joined the company.
Cabenuva: The First Long-Acting HIV Treatment🧬🧪💉

The first long-acting drug combination for HIV, to be administered monthly after the successful approval from the United States regulators. Thursday’s authorization of the two-shot combination, referred to as Cabenuva, is anticipated to make it less complicated for individuals to follow proper medication as well as to give more privacy.

About

About basic Biotech

Advertise With us

Contact us

Meet our team

Careers

Privacy and Term

Subcribe

Basic Biotech Newsletter

Basic Biotech Podcast

Connect